Globally, liver cancer, also known as Hepatic cancer, accounts for the third highest cancer mortality rate. The major causes of liver cancer include hepatitis B, hepatitis C, alcoholic steatohepatitis and non-alcoholic steatohepatitis (NASH). Multicellular signaling pathways are associated with hepatocarcinogenesis, such as PI3K/Akt/mTOR signaling pathway, epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), etc.

The TargetMol Anti-Liver Cancer Compound Library is a collection of 1816 compounds related to liver cancer, including compounds that have been reported to have therapeutic effects in liver cancer, as well as compounds that target liver cancer-related targets, and is a good tool for anti-liver cancer drug development.